NO20091057L - Oral legemiddelform for prevensjon - Google Patents

Oral legemiddelform for prevensjon

Info

Publication number
NO20091057L
NO20091057L NO20091057A NO20091057A NO20091057L NO 20091057 L NO20091057 L NO 20091057L NO 20091057 A NO20091057 A NO 20091057A NO 20091057 A NO20091057 A NO 20091057A NO 20091057 L NO20091057 L NO 20091057L
Authority
NO
Norway
Prior art keywords
birth control
dienogest
oral form
less
daily dose
Prior art date
Application number
NO20091057A
Other languages
English (en)
Inventor
Herbert Wiesinger
Hagen Gerecke
Sabine Fricke
Ralf Ladwig
Alexander Buske
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of NO20091057L publication Critical patent/NO20091057L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

Oral legemiddelform for prevensjon omfatter som en aktiv forbindelse, 17a-cyanometyl-17-ß-hydroksyøstra-4,9-dien-3-on (dienogest) i en daglig dose lik eller mindre enn 2,0 mg og som annen aktiv komponent 17a-etynyløstradiol (etynyløstradiol) i en daglig dose på mindre enn 0,03 mg, sammen med én eller flere farmasøytisk akseptable bærere. Den aktive bestanddel dienogest er til stede i krystallinsk form med en midlere partikkelstørrelse på fra 25 til 70 µm. Den aktive bestanddel etynyløstradiol er innført i mikronisert form eller som etanolisk løsning under granuleringen.
NO20091057A 2006-08-10 2009-03-09 Oral legemiddelform for prevensjon NO20091057L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06016694A EP1886694B1 (de) 2006-08-10 2006-08-10 Perorale Arzneiform mit Dienogest und Ethinylestradiol zur Kontrazeption
PCT/EP2007/003662 WO2008017331A2 (de) 2006-08-10 2007-04-26 Perorale arzneiform mit dienogest und ethinylestradiol zur kontrazeption

Publications (1)

Publication Number Publication Date
NO20091057L true NO20091057L (no) 2009-03-09

Family

ID=37561777

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091057A NO20091057L (no) 2006-08-10 2009-03-09 Oral legemiddelform for prevensjon

Country Status (18)

Country Link
EP (1) EP1886694B1 (no)
AR (1) AR062323A1 (no)
AT (1) ATE432714T1 (no)
CL (1) CL2007002323A1 (no)
CY (1) CY1110348T1 (no)
DE (1) DE502006003892D1 (no)
DK (1) DK1886694T3 (no)
DO (1) DOP2007000122A (no)
ES (1) ES2327665T3 (no)
HR (1) HRP20090438T1 (no)
NO (1) NO20091057L (no)
PE (1) PE20080541A1 (no)
PL (1) PL1886694T3 (no)
PT (1) PT1886694E (no)
SI (1) SI1886694T1 (no)
TW (1) TW200817012A (no)
UY (1) UY30530A1 (no)
WO (1) WO2008017331A2 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010003711B4 (de) * 2010-04-08 2015-04-09 Jesalis Pharma Gmbh Verfahren zur Herstellung kristalliner Wirkstoffpartikel
CN115487198B (zh) * 2022-09-20 2024-01-02 华中药业股份有限公司 一种快溶出度的左炔诺孕酮制剂及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1216713A1 (en) * 2000-12-20 2002-06-26 Schering Aktiengesellschaft Compositions of estrogen-cyclodextrin complexes
DE10218107A1 (de) * 2002-04-23 2003-11-20 Jenapharm Gmbh Verfahren zum Herstellen von Kristallen von Steroiden, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen

Also Published As

Publication number Publication date
AR062323A1 (es) 2008-10-29
ATE432714T1 (de) 2009-06-15
WO2008017331A3 (de) 2009-01-08
SI1886694T1 (sl) 2009-10-31
TW200817012A (en) 2008-04-16
PL1886694T3 (pl) 2009-11-30
CL2007002323A1 (es) 2008-02-15
ES2327665T3 (es) 2009-11-02
UY30530A1 (es) 2008-03-31
PE20080541A1 (es) 2008-07-10
WO2008017331A2 (de) 2008-02-14
EP1886694B1 (de) 2009-06-03
PT1886694E (pt) 2009-08-17
HRP20090438T1 (en) 2009-09-30
EP1886694A1 (de) 2008-02-13
DK1886694T3 (da) 2009-09-28
DOP2007000122A (es) 2008-02-15
CY1110348T1 (el) 2015-04-29
DE502006003892D1 (de) 2009-07-16

Similar Documents

Publication Publication Date Title
US8063030B2 (en) Extended cycle multiphasic oral contraceptive method
NZ602698A (en) Parenteral pharmaceutical form which releases aromatase inhibitor and gestagens, for the treatment of endometriosis
JP2008540482A5 (no)
JP2010180236A5 (no)
EA200900491A1 (ru) Применение эстрадиола валерата или 17в-эстрадиола в комбинации с диеногестом для перорального лечения для поддержания и/или повышения полового влечения у особи женского пола
NZ605176A (en) Pharmaceutical composition comprising drospirenone and contraceptive kit
CA2608639A1 (en) Pharmaceutical composition comprising progestogens and/or estrogens and 5-methyl-(6s)-tetrahydrofolate
HRP20240121T1 (hr) Kontracepcija na bazi drospirenona za pacijenticu s viškom tjelesne težine
AR061959A1 (es) Composicion farmaceutica para la anticoncepcion y para reducir el riesgo de malformaciones congenitas
NO327588B1 (no) Farmasoytisk sammensetning og preparat omfattende etinylostradiol og drospirenon for anvendelse som antikonsepsjonsmiddel
NO20056153L (no) Preparat omfattende antiprogestiner og rene antiostrogener for profylakse og behandling av hormon-avhengige sykdommer
NO20091057L (no) Oral legemiddelform for prevensjon
TW200638951A (en) Solid oral pharmaceutical form for contraception
EA200701389A1 (ru) Твёрдая пероральная лекарственная форма для контрацепции
NO20072687L (no) Farmasoytisk prevensjonspreparat
TW200731977A (en) Use of estradiol valerate in combination with dienogest for the oral treatment of dysfunctional uterine bleeding in conjunction with oral contraception
MX2009007259A (es) Preparacion farmaceutica para reducir la endometriosis.
UY29378A1 (es) Preparación farmaceutica para la anticoncepción oral
PE20091020A1 (es) Uso de un gestageno en combinacion con un estrogeno y uno o varios excipientes/portadores farmaceuticamente aceptables para la anticoncepcion oral sin lactosa
TH80558A (th) รูปแบบยาทางช่องปากชนิดแข็งสำหรับการคุมกำเนิด
RS50849B (sr) Upotreba estradiolvalerata i dienogesta za oralno lečenje disfunkcionalnog uterinog krvarenja u kontracepcijskom metodu
JO2213B1 (en) A pharmaceutical composition for use as a contraceptive method
RU2009135418A (ru) Однофазный фармацевтический композитный препарат (диеногеста и этинилэстрадиола) для пероральной терапии для регулирования артериального давления
RU2009140372A (ru) Новый режим с дроспиреноном/17b-эстрадиолом, фармацевтический комбинированный продукт и набор для выполнения этого режима

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application